Date published: 2026-4-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

BM88 Inhibitors

BM88 inhibitors are chemical agents designed to interact with and inhibit the activity of the BM88 protein, also known as Cend1, which is involved in cellular differentiation and proliferation processes. BM88 is primarily expressed in the nervous system and has been implicated in the regulation of neural development. The exact mechanisms of BM88 action are not fully delineated, but it is believed to play a role in the transition of cells from proliferative states to differentiated states. BM88 inhibitors, therefore, aim to modulate this transition by directly binding to the BM88 protein or interfering with its signaling pathways. The inhibition of BM88 could affect the protein's ability to interact with other cellular components or its capacity to regulate gene expression, ultimately impacting the cellular processes in which BM88 is involved. These inhibitors could bind to the active site of the protein, or they might interact allosterically, changing the conformation of BM88 in a way that diminishes its functional activity.

The development and characterization of BM88 inhibitors involve a multifaceted approach that includes the use of computational modeling, synthetic chemistry, and various biological assays. Initial efforts might focus on the use of computational tools to predict the structure of BM88 and potential binding sites for inhibitors. Such in silico studies facilitate the design of molecules that could interact with specific domains of BM88, potentially leading to the inhibition of its function. Synthetic chemists would then synthesize these molecules, which are subsequently tested for their ability to bind to and inhibit BM88. Various in vitro assays can be employed to assess the binding affinity and inhibitory potency of these molecules, including but not limited to, fluorescence-based assays, surface plasmon resonance, and isothermal titration calorimetry. Following the identification of promising inhibitory compounds, further studies are conducted to understand how these inhibitors interact with the BM88 protein at the molecular level.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Inhibits the vacuolar H+ ATPase, affecting endosomal acidification and potentially influencing BM88-related trafficking.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$100.00
$321.00
$2289.00
$4484.00
$18207.00
$34749.00
3
(2)

Disrupts microtubule polymerization, which could alter cytoskeletal dynamics and indirectly impact BM88 function.

Cyclopiazonic Acid

18172-33-3sc-201510
sc-201510A
10 mg
50 mg
$176.00
$624.00
3
(1)

Inhibits sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), potentially disrupting calcium homeostasis affecting BM88-related signaling.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Inhibits protein synthesis, which could affect overall neuronal protein homeostasis including BM88.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

Inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII), potentially affecting neuronal functions related to BM88.

Chelerythrine chloride

3895-92-9sc-3547
sc-3547A
5 mg
25 mg
$90.00
$317.00
17
(1)

Inhibits protein kinase C, which could influence signaling pathways involving BM88.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK, which is involved in the MAPK/ERK pathway, potentially affecting BM88 downstream signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, affecting the PI3K/Akt pathway and potentially altering BM88-mediated processes.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

Inhibits protein kinase C, which may modulate BM88-related signaling pathways.